Ark Invest boosts Bullish stake by $11.98 million despite stock slump

Fuente Cryptopolitan

Cathy Wood-backed Ark Invest has increased its stake in Peter Thiel-backed crypto exchange Bullish by $11.98 million, adding to the already existing $172 million position. As of November 3, Bullish accounts for 1.18% of Ark Invest’s ARKF’s portfolio, 0.98% of ARKW, and 0.97% of its flagship ETF ARKK’s holdings. 

Ark Invest acquired a total of 238,3346 shares, with ARK Innovation ETF (ARKK) getting the lion’s share of 164,214 shares. ARK Next Generation Internet ETF (ARKW) followed with 49,056 shares, and the ARK Fintech Innovation ETF added 25,076 shares. Together, ARK Invest’s total investment in Bullish since its August debut on the New York Stock Exchange exceeds $209 million.

However, data shows that Bullish (BLSH) has been on a constant decline YTD. Bullish has dropped by 47.48%, both YTD and over the past six months, and 22% in the past month. It has also lost 10.74% over the past five days and 0.61% (-0.31%) over the past 24 hours. The stock’s pre-market plunge saw Bullish drop to $49.05, representing a 2.47 drop (-1.23).   

ARK Invest’s faith remains Bullish

ARK Invest has chosen to hold on to its faith in Bullish despite the exchange’s dismal performance this year. Data indicate that the exchange has been in a constant decline since its launch, with a decline of roughly 47%.

However, a recent boost from institutional traders has seen the exchange’s new crypto options platform attract a five-day trading volume of nearly $82 million.

Institutional partners, including Block Tech, FalconX Global, and Wintermute, participated in the launch. The company began operations with Nonco and BitGo after launching in 2021 and has processed more than $1.5 trillion in trading volume.

The Bullish team stated that the exchange’s new options product aims to address the pain points in crypto options trading that exist today. The exchange received authorization for spot trading in the U.S. at the beginning of October, following the issuance of its BitLicense and Money Transmission License by the New York State Department of Financial Services in September. 

Meanwhile, ARK Invest’s latest purchase of Bullish shares reportedly aligns with its long-standing strategy of investing in disruptive innovation. The investment firm currently manages assets exceeding $16 billion, with a focus on AI, blockchain technology, robotics, and genomics.

Tyrer claims Bullish was created for institutions

Chris Tyrer, the president of Bullish, previously stated that the exchange was designed for institutional clients, and the U.S. launch introduces a platform that combines institutional-grade liquidity and cost efficiency.

He added that while advanced individual traders were welcomed to the platform, the focus is on U.S. institutions. Tyrer believes that U.S. institutions deserve deeper liquidity, better execution, and a platform uniquely designed to meet their specific demands and strategies. 

The Partner and Head of North America at Nonco, Jeffrey Howard, also echoed Tyrer’s sentiment, claiming that Bullish is redefining what institutional investors should expect from a licensed U.S. exchange serving Americans.    

Howard also pointed out that Bullish’s focus on compliance, liquidity, and the quality of execution aligns with Nonco’s mission to deliver to its clients. He added that Bullish’s U.S. launch across 20 states as an OTC liquidity provider, focusing on market structure, is a meaningful step toward institutional adoption. 

BitGo’s co-founder and CEO Mike Belshe also observed that the exchange’s NYDFS approvals mark a crucial milestone for U.S.-compliant crypto innovation.

He claimed that his company is entirely behind Bullish’s expansion and commitment to regulatory compliance. Belshe believes that the milestone highlights the importance of establishing a transparent and secure cryptocurrency ecosystem for institutions.  

Meanwhile, the Bullish team claimed that the company’s platform combines deterministic AMM (automated market maker) and a CLOB (central limit order book) to provide efficient trade execution and deep, stable liquidity, even during volatile market conditions. Key features available to U.S. institutional investors include 0% maker fees and low taker fees.

Get seen where it counts. Advertise in Cryptopolitan Research and reach crypto’s sharpest investors and builders.

Descargo de responsabilidad: Sólo con fines informativos. Rentabilidades pasadas no son indicativas de resultados futuros.
placeholder
Pronóstico del Precio del EUR/JPY: Se mueve por debajo de la zona de soporte de confluencia alrededor de 177.00El EUR/JPY se deprecia más de 0.25% tras mantenerse plano en la sesión anterior, cotizando alrededor de 176.80 durante las horas europeas del martes.
Autor  FXStreet
10 hace una horas
El EUR/JPY se deprecia más de 0.25% tras mantenerse plano en la sesión anterior, cotizando alrededor de 176.80 durante las horas europeas del martes.
placeholder
Los dirigentes monetarios de la Fed se muestran divididos ante la reunión de diciembreLos responsables de la Reserva Federal (Fed) continuaron el lunes con opiniones contrapuestas sobre la situación de la economía y los riesgos que enfrenta, un debate que se intensificará antes de la próxima reunión de política monetaria del banco central de Estados Unidos y en ausencia de datos suspendidos por al cierre de la Administración federal.
Autor  Reuters
11 hace una horas
Los responsables de la Reserva Federal (Fed) continuaron el lunes con opiniones contrapuestas sobre la situación de la economía y los riesgos que enfrenta, un debate que se intensificará antes de la próxima reunión de política monetaria del banco central de Estados Unidos y en ausencia de datos suspendidos por al cierre de la Administración federal.
placeholder
Las acciones de Sarepta se desploman después de que el ensayo de fármacos para la enfermedad de desgaste muscular no alcance su objetivo claveSarepta SRPT.O dijo el lunes que su estudio de última etapa probando dos terapias dirigidas a genes para la distrofia muscular de Duchenne no cumplió con el objetivo principal, enviando sus acciones a desplomarse más del 37% en el comercio extendido.
Autor  Reuters
18 hace una horas
Sarepta SRPT.O dijo el lunes que su estudio de última etapa probando dos terapias dirigidas a genes para la distrofia muscular de Duchenne no cumplió con el objetivo principal, enviando sus acciones a desplomarse más del 37% en el comercio extendido.
placeholder
Oro Previsión del Precio: XAU/USD se mantiene por debajo de 4.000$ mientras los comentarios de línea dura de la Fed elevan al Dólar estadounidenseEl precio del Oro (XAU/USD) desciende a alrededor de 4.000$ durante la primera parte de la sesión asiática del martes. El metal precioso se mueve a la baja a medida que los operadores reducen sus apuestas por más recortes de tasas de la Reserva Federal (Fed). La gobernadora de la Fed, Michelle Bowman, está programada para hablar más tarde en el día
Autor  FXStreet
18 hace una horas
El precio del Oro (XAU/USD) desciende a alrededor de 4.000$ durante la primera parte de la sesión asiática del martes. El metal precioso se mueve a la baja a medida que los operadores reducen sus apuestas por más recortes de tasas de la Reserva Federal (Fed). La gobernadora de la Fed, Michelle Bowman, está programada para hablar más tarde en el día
placeholder
USD/JPY se fortalece por encima de 154.00 por el tono de línea dura de la FedEl par USD/JPY gana fuerza hasta cerca de 154,20 durante la sesión asiática temprana del martes. El Dólar estadounidense (USD) se mueve al alza frente al Yen japonés (JPY) ante la posibilidad de que la Reserva Federal de EE.UU. (Fed) mantenga su tasa de interés en diciembre
Autor  FXStreet
19 hace una horas
El par USD/JPY gana fuerza hasta cerca de 154,20 durante la sesión asiática temprana del martes. El Dólar estadounidense (USD) se mueve al alza frente al Yen japonés (JPY) ante la posibilidad de que la Reserva Federal de EE.UU. (Fed) mantenga su tasa de interés en diciembre
goTop
quote